Delivery Order SPE2DB24D2100-SPE2DB25FBDJN
Award Date
4/8/25
Potential Completion Date
4/9/25
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,237.14, is for the delivery of RYTARY ER 23.75 MG-95 MG capsules, a medication used in the treatment of Parkinson's disease. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 2, 2025. This award is not associated with a set-aside designation....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $8,115.93, is for the delivery of RYTARY ER 61.25 MG-245 MG capsules, a medication used for the treatment of Parkinson's disease. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,733.90, is for the provision of RYTARY ER 48.75 MG-195 MG capsules, a medication used to treat Parkinson's disease. The contract has an ultimate completion date of July 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $9,452.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RYTARY ER 23.75 MG-95 MG capsules, a medication used in the treatment of Parkinson's disease. The contract has an ultimate completion date of October 31, 2023 and is structured as a firm fixed price delivery order. There was no set-aside requirement for this award. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $28,874.37, is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,313.68 firm fixed price delivery order is for the supply of RYTARY ER 23.75 MG-95 MG capsules, a medication used to treat Parkinson's disease. The contract has a completion date of November 13, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $13,734.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rytary ER 23.75 mg-95 mg capsules, a medication used to treat Parkinson's disease. The contract is a firm fixed-price delivery order with an ultimate completion date of April 16, 2025. This award is not associated with a set-aside program and is part of a larger...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,829.51, is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of July 9, 2024. This award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,848.65, is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a prescription pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 11, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $4,807.37, is for the delivery of RYTARY ER 23.75 MG-95 MG CAP 100S, a prescription medication. The contract is a Delivery Order under a Firm Fixed Price pricing type, with a completion date of March 14, 2025. The contract was awarded on March 13, 2025 and does not have a set-aside designation,...